Liquid Biopsy Market Size, Share, Trends, Growth 2032

Liquid Biopsy Market

Liquid Biopsy Market By Target Analyte (Circulating Tumor Cells (Ctcs), Circulating Tumor DNA (CtDNA), Exosomes, Nucleosomes, and Other Biomarkers), By Analytical (Molecular, Proteomic, and Histology/Imaging), By Application (Routine Screening, Patient Work-Up, Early-Stage Disease, and Late-Stage/Metastatic Disease), By Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Brain Cancer, and Others), By Sample (Blood, Urine, and Others), and by End-User (Hospitals, Research Laboratories, Academia, and Research Centers), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 130 Report Code: ZMR-884 Published Date: Sep-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 5.71 Billion USD 16.22 Billion 12.3% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Liquid Biopsy Market, 2016-2025 (USD Million)
    • 2.2. Liquid Biopsy Market: Market Snapshot
  •  
  • Chapter 3. Liquid Biopsy Market - Industry Analysis
    • 3.1. Liquid Biopsy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rising incidences of cancer
      • 3.2.2. Growing demand for minimally invasive surgeries
      • 3.2.3. Escalating demand for personalized medicine
      • 3.2.4. Rising healthcare expenditure
    • 3.3. Restraints
      • 3.3.1. Stringent regulatory policies
      • 3.3.2. Lack of clarity in medical pricing
      • 3.3.3. Unclear reimbursement policies
      • 3.3.4. Alternatives to liquid biopsies
    • 3.4. Opportunity
      • 3.4.1. Expanding in-vitro diagnostic market
      • 3.4.2. Emerging economies like India and China
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by target analyte
      • 3.6.2. Market attractiveness analysis by analytical
      • 3.6.3. Market attractiveness analysis by cancer type
      • 3.6.4. Market attractiveness analysis by application
      • 3.6.5. Market attractiveness analysis by sample
      • 3.6.6. Market attractiveness analysis by end-user
      • 3.6.7. Market attractiveness analysis by region
  •  
  • Chapter 4. Liquid Biopsy Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global liquid biopsy market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Liquid Biopsy Market - Target Analyte Analysis
    • 5.1. Global liquid biopsy market overview: by target analyte
      • 5.1.1. Global liquid biopsy market revenue share, by target analyte, 2018 and 2025
    • 5.2. Circulating Tumor Cells
      • 5.2.1. Global liquid biopsy market by circulating tumor cells, 2016-2025 (USD Million)
    • 5.3. Circulating Tumor DNA
      • 5.3.1. Global liquid biopsy market by circulating tumor DNA, 2016-2025 (USD Million)
    • 5.4. Exosomes
      • 5.4.1. Global liquid biopsy market by exosomes, 2016-2025 (USD Million)
    • 5.5. Nucleosomes
      • 5.5.1. Global liquid biopsy market by nucleosomes, 2016-2025 (USD Million)
    • 5.6. Biomarkers
      • 5.6.1. Global liquid biopsy market by other biomarkers, 2016-2025 (USD Million)
  •  
  • Chapter 6. Global Liquid Biopsy Market - Analytical Analysis
    • 6.1. Global liquid biopsy market overview: by analytical
      • 6.1.1. Global liquid biopsy market revenue share, by analytical, 2018 and 2025
    • 6.2. Molecular
      • 6.2.1. Global liquid biopsy market by molecular, 2016-2025 (USD Million)
    • 6.3. Proteomic
      • 6.3.1. Global liquid biopsy market by proteomic, 2016-2025 (USD Million)
    • 6.4. Histology/ Imaging
      • 6.4.1. Global liquid biopsy market by histology/imaging, 2016-2025 (USD Million)
  •  
  • Chapter 7. Global Liquid Biopsy Market - Application Analysis
    • 7.1. Global liquid biopsy market overview: by application
      • 7.1.1. Global liquid biopsy market revenue share, by application, 2018 and 2025
    • 7.2. Routine Screening
      • 7.2.1. Global liquid biopsy market for routine screening, 2016-2025 (USD Million)
    • 7.3. Patient Work-Up
      • 7.3.1. Global liquid biopsy market for patient work-up, 2016-2025 (USD Million)
    • 7.4. Early Stage Disease
      • 7.4.1. Global liquid biopsy market for early-stage disease, 2016-2025 (USD Million)
    • 7.5. Late Stage/ Metastatic Disease
      • 7.5.1. Global liquid biopsy market for late stage/metastatic disease, 2016-2025 (USD Million)
  •  
  • Chapter 8. Global Liquid Biopsy Market - Cancer Type Analysis
    • 8.1. Global liquid biopsy market overview: by cancer type
      • 8.1.1. Global liquid biopsy market revenue share, by cancer type, 2018 and 2025
    • 8.2. Breast Cancer
      • 8.2.1. Global liquid biopsy market for breast cancer, 2016-2025 (USD Million)
    • 8.3. Prostate Cancer
      • 8.3.1. Global liquid biopsy market for prostate cancer, 2016-2025 (USD Million)
    • 8.4. Colorectal Cancer
      • 8.4.1. Global liquid biopsy market for colorectal cancer, 2016-2025 (USD Million)
    • 8.5. Brain Cancer
      • 8.5.1. Global liquid biopsy market for brain cancer, 2016-2025 (USD Million)
    • 8.6. Lung Cancer
      • 8.6.1. Global liquid biopsy market for lung cancer, 2016-2025 (USD Million)
    • 8.7. Other
      • 8.7.1. Global liquid biopsy market for others, 2016-2025 (USD Million)
  •  
  • Chapter 9. Global Liquid Biopsy Market - Sample Analysis
    • 9.1. Global liquid biopsy market overview: by sample
      • 9.1.1. Global liquid biopsy market revenue share, by sample, 2018 and 2025
    • 9.2. Blood
      • 9.2.1. Global liquid biopsy market for blood, 2016-2025 (USD Million)
    • 9.3. Urine
      • 9.3.1. Global liquid biopsy market for urine, 2016-2025 (USD Million)
    • 9.4. Others
      • 9.4.1. Global liquid biopsy market for others, 2016-2025 (USD Million)
  •  
  • Chapter 10. Global Liquid Biopsy Market - End-User Analysis
    • 10.1. Global liquid biopsy market overview: by end-user
      • 10.1.2. Global liquid biopsy market revenue share, by end-user, 2018 and 2025
    • 10.2. Hospitals
      • 10.2.1. Global liquid biopsy market for hospitals, 2016-2025 (USD Million)
    • 10.3. Research Laboratories
      • 10.3.1. Global liquid biopsy market for research laboratories, 2016-2025 (USD Million)
    • 10.4. Academia
      • 10.4.1. Global liquid biopsy market for academia, 2016-2025 (USD Million)
    • 10.5. Research Centers
      • 10.5.1. Global liquid biopsy market for research centers, 2016-2025 (USD Million)
  •  
  • Chapter 11. Global Liquid Biopsy Market - Regional Analysis
    • 11.1. Global liquid biopsy market overview: by region
      • 11.1.1. Global liquid biopsy market revenue share, by region, 2018 and 2025
    • 11.2. North America
      • 11.2.1. North America liquid biopsy market, 2016-2025 (USD Million)
      • 11.2.2. North America liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.2.3. North America liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.2.4. North America liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.2.5. North America liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
      • 11.2.6. North America liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.2.7. North America liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.2.8. The U.S.
        • 11.2.8.1. The U.S. Liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.2.8.2. The U.S. Liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.2.8.3. The U.S. Liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.2.8.4. The U.S. Liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.2.8.5. The U.S. Liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.2.8.6. The U.S. Liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.2.9. Canada
        • 11.2.9.1. Canada liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.2.9.2. Canada liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.2.9.3. Canada liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.2.9.4. Canada liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.2.9.5. Canada liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.2.9.6. Canada liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
    • 11.3. Europe
      • 11.3.1. Europe liquid biopsy market, 2016-2025 (USD Million)
      • 11.3.2. Europe liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.3.3. Europe liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.3.4. Europe liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.3.5. Europe liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
      • 11.3.6. Europe liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.3.7. Europe liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.3.8. U.K.
        • 11.3.8.1. U.K. liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.3.8.2. U.K. liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.3.8.3. U.K. liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.3.8.4. U.K. liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.3.8.5. U.K. liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.3.8.6. U.K. liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.3.9. France
        • 11.3.9.1. France liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.3.9.2. France liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.3.9.3. France liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.3.9.4. France liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.3.9.5. France liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.3.9.6. France liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.3.10. Germany
        • 11.3.10.1. Germany liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.3.10.2. Germany liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.3.10.3. Germany liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.3.10.4. Germany liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.3.10.5. Germany liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.3.10.6. Germany liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.3.11. Rest of Europe
        • 11.3.11.1. Rest of Europe liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.3.11.2. Rest of Europe liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.3.11.3. Rest of Europe liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.3.11.4. Rest of Europe liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.3.11.5. Rest of Europe liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.3.11.6. Rest of Europe liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
    • 11.4. Asia Pacific
      • 11.4.1. Asia Pacific liquid biopsy market, 2016-2025 (USD Million)
      • 11.4.2. Asia Pacific liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.4.3. Asia Pacific liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.4.4. Asia Pacific liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.4.5. Asia Pacific liquid biopsy market revenue, by cancertype, 2016-2025 (USD Million)
      • 11.4.6. Asia Pacific liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.4.7. Asia Pacific liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.4.8. China
        • 11.4.8.1. China liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.4.8.2. China liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.4.8.3. China liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.4.8.4. China liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.4.8.5. China liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.4.8.6. China liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.4.9. Japan
        • 11.4.9.1. Japan liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.4.9.2. Japan liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.4.9.3. Japan liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.4.9.4. Japan liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.4.9.5. Japan liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.4.9.6. Japan liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.4.10. India
        • 11.4.10.1. India liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.4.10.2. India liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.4.10.3. India liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.4.10.4. India liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.4.10.5. India liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.4.10.6. India liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.4.11. Rest of Asia Pacific
        • 11.4.11.1. Rest of Asia Pacific liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.4.11.2. Rest of Asia Pacific liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.4.11.3. Rest of Asia Pacific liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.4.11.4. Rest of Asia Pacific liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.4.11.5. Rest of Asia Pacific liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.4.11.6. Rest of Asia Pacific liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
    • 11.5. Latin America
      • 11.5.1. Latin America liquid biopsy market, 2016-2025 (USD Million)
      • 11.5.2. Latin America liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.5.3. Latin America liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.5.4. Latin America liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.5.5. Latin America liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
      • 11.5.6. Latin America liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.5.7. Latin America liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.5.8. Brazil
        • 11.5.8.1. Brazil liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.5.8.2. Brazil liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.5.8.3. Brazil liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.5.8.4. Brazil liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.5.8.5. Brazil liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.5.8.6. Brazil liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.5.9. Rest of Latin America
        • 11.5.9.1. Rest of Latin America liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.5.9.2. Rest of Latin America liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.5.9.3. Rest of Latin America liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.5.9.4. Rest of Latin America liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.5.9.5. Rest of Latin America liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.5.9.6. Rest of Latin America liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
    • 11.6. The Middle East and Africa
      • 11.6.1. The Middle East and Africa liquid biopsy market, 2016-2025 (USD Million)
      • 11.6.2. The Middle East and Africa liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.6.3. The Middle East and Africa liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.6.4. The Middle East and Africa liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.6.5. The Middle East and Africa liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
      • 11.6.6. The Middle East and Africa liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.6.7. The Middle East and Africa liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
  •  
  • Chapter 12. Company Profiles
    • 12.1. Personal Genome Diagnostics
      • 12.1.1. Overview
      • 12.1.2. Financials
      • 12.1.3. Product Portfolio
      • 12.1.4. Business Strategy
      • 12.1.5. Recent Developments
    • 12.2. Biocept
      • 12.2.1. Overview
      • 12.2.2. Financials
      • 12.2.3. Product Portfolio
      • 12.2.4. Business Strategy
      • 12.2.5. Recent Developments
    • 12.3. Adaptive Biotechnologies
      • 12.3.1. Overview
      • 12.3.2. Financials
      • 12.3.3. Product Portfolio
      • 12.3.4. Business Strategy
      • 12.3.5. Recent Developments
    • 12.4. Cynvenio
      • 12.4.1. Overview
      • 12.4.2. Financials
      • 12.4.3. Product Portfolio
      • 12.4.4. Business Strategy
      • 12.4.5. Recent Developments
    • 12.5. NeoGenomics Laboratories
      • 12.5.1. Overview
      • 12.5.2. Financials
      • 12.5.3. Product Portfolio
      • 12.5.4. Business Strategy
      • 12.5.5. Recent Development
    • 12.6. Qiagen
      • 12.6.1. Overview
      • 12.6.2. Financials
      • 12.6.3. Product Portfolio
      • 12.6.4. Business Strategy
      • 12.6.5. Recent Developments
    • 12.7. Trovagene
      • 12.7.1. Overview
      • 12.7.2. Financials
      • 12.7.3. Product Portfolio
      • 12.7.4. Business Strategy
      • 12.7.5. Recent Developments
    • 12.8. RainDance Technologies
      • 12.8.1. Overview
      • 12.8.2. Financials
      • 12.8.3. Product Portfolio
      • 12.8.4. Business Strategy
      • 12.8.5. Recent Developments
    • 12.9. Guardant Health
      • 12.9.1. Overview
      • 12.9.2. Financials
      • 12.9.3. Product Portfolio
      • 12.9.4. Business Strategy
      • 12.9.5. Recent Developments
    • 12.10. Exosome Diagnostics
      • 12.10.1. Overview
      • 12.10.2. Financials
      • 12.10.3. Product Portfolio
      • 12.10.4. Business Strategy
      • 12.10.5. Recent Developments
    • 12.11. Exosome Diagnostics
      • 12.11.1. Overview
      • 12.11.2. Financials
      • 12.11.3. Product Portfolio
      • 12.11.4. Business Strategy
      • 12.11.5. Recent Developments
    • 12.12. Circulogene Theranostics
      • 12.12.1. Overview
      • 12.12.2. Financials
      • 12.12.3. Product Portfolio
      • 12.12.4. Business Strategy
      • 12.12.5. Recent Developments
    • 12.13. Inivata
      • 12.13.1. Overview
      • 12.13.2. Financials
      • 12.13.3. Product Portfolio
      • 12.13.4. Business Strategy
      • 12.13.5. Recent Developments
    • 12.14. Agena Bioscience
      • 12.14.1. Overview
      • 12.14.2. Financials
      • 12.14.3. Product Portfolio
      • 12.14.4. Business Strategy
      • 12.14.5. Recent Developments
    • 12.15. Exosome Diagnostics
      • 12.15.1. Overview
      • 12.15.2. Financials
      • 12.15.3. Product Portfolio
      • 12.15.4. Business Strategy
      • 12.15.5. Recent Developments
    • 12.16. Admeria Health
      • 12.16.1. Overview
      • 12.16.2. Financials
      • 12.16.3. Product Portfolio
      • 12.16.4. Business Strategy
      • 12.16.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global liquid biopsy market, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global liquid biopsy market attractiveness, by target analyte
6. Global liquid biopsy market attractiveness, by analytical
7. Global liquid biopsy market attractiveness, by cancer type
8. Global liquid biopsy market attractiveness, by application
9. Global liquid biopsy market attractiveness, by sample
10. Global liquid biopsy market attractiveness, by end-use
11. Global liquid biopsy market attractiveness, by region
12. Liquid biopsy market revenue share, by target analyte, 2018 and 2025
13. Global liquid biopsy market by circulating tumor cells, 2016–2025 (USD Million)
14. Global liquid biopsy market by circulating tumor DNA, 2016–2025 (USD Million)
15. Global liquid biopsy market by exosomes, 2016–2025 (USD Million)
16. Global liquid biopsy market by nucleosomes, 2016–2025 (USD Million)
17. Global liquid biopsy market by other biomarkers, 2016–2025 (USD Million)
18. Global liquid biopsy market revenue share, by analytical, 2018 and 2025
19. Global liquid biopsy market by molecular, 2016–2025 (USD Million)
20. Global liquid biopsy market by proteomic, 2016–2025 (USD Million)
21. Global liquid biopsy market by histology/imaging, 2016–2025 (USD Million)
22. Global liquid biopsy market revenue share, by application, 2018 and 2025
23. Global liquid biopsy market for routine screening, 2016–2025 (USD Million)
24. Global liquid biopsy market for patient work-up, 2016–2025 (USD Million)
25. Global liquid biopsy market for early-stage disease, 2016–2025 (USD Million)
26. Global liquid biopsy market for late stage/metastatic disease, 2016–2025 (USD Million)
27. Global liquid biopsy market revenue share, by sample, 2018 and 2025
28. Global liquid biopsy market for blood, 2016–2025 (USD Million)
29. Global liquid biopsy market for urine, 2016–2025 (USD Million)
30. Global liquid biopsy market for others, 2016–2025 (USD Million)
31. Global liquid biopsy market revenue share, by cancer type, 2018 and 2025
32. Global liquid biopsy market for breast cancer, 2016–2025 (USD Million)
33. Global liquid biopsy market for prostate cancer, 2016–2025 (USD Million)
34. Global liquid biopsy market for colorectal cancer, 2016–2025 (USD Million)
35. Global liquid biopsy market for lung cancer, 2016–2025 (USD Million)
36. Global liquid biopsy market for brain cancer, 2016–2025 (USD Million)
37. Global liquid biopsy market for others, 2016–2025 (USD Million)
38. Global liquid biopsy market revenue share, by end-use, 2018 and 2025
39. Global liquid biopsy market for hospitals, 2016–2025 (USD Million)
40. Global liquid biopsy market for research laboratories, 2016–2025 (USD Million)
41. Global liquid biopsy market for academia, 2016–2025 (USD Million)
42. Global liquid biopsy market for research centers, 2016–2025 (USD Million)
43. Global liquid biopsy market revenue share, by region, 2019 & 2025
44.  North America liquid biopsy market, 2016–2025 (USD Million)
45.  Europe liquid biopsy market, 2016–2025 (USD Million)
46.  Asia Pacific liquid biopsy market, 2016–2025 (USD Million)
47.  Latin America liquid biopsy market, 2016–2025 (USD Million)
48.  The Middle East and Africa liquid biopsy market, 2016–2025 (USD Million)


Table Of Tables

List of Tables

1. Global liquid biopsy market: snapshot
2. Drivers for the liquid biopsy market: impact analysis
3. Restraints for liquid biopsy market: impact analysis
4. North America liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
5. North America liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
6. North America liquid biopsy market revenue, by application, 2016–2025 (USD Million)
7. North America liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
8. North America liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
9. North America liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
10. The U.S. Liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
11. The U.S. Liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
12. The U.S. Liquid biopsy market revenue, by application, 2016–2025 (USD Million)
13. The U.S. Liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
14. The U.S. Liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
15. The U.S. Liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
16. Canada liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
17. Canada liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
18. Canada liquid biopsy market revenue, by application, 2016–2025 (USD Million)
19. Canada liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
20. Canada liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
21. Canada liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
22. Europe liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
23. Europe liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
24. Europe liquid biopsy market revenue, by application, 2016–2025 (USD Million)
25. Europe liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
26. Europe liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
27. Europe liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
28. U.K. liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
29. U.K. liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
30. U.K. liquid biopsy market revenue, by application, 2016–2025 (USD Million)
31. U.K. liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
32. U.K. liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
33. U.K. liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
34. France liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
35. France liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
36. France liquid biopsy market revenue, by application, 2016–2025 (USD Million)
37. France liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
38. France liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
39. France liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
40. Germany liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
41. Germany liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
42. Germany liquid biopsy market revenue, by application, 2016–2025 (USD Million)
43. Germany liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
44. Germany liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
45. Germany liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
46. Rest of Europe liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
47. Rest of Europe liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
48. Rest of Europe liquid biopsy market revenue, by application, 2016–2025 (USD Million)
49. Rest of Europe liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
50. Rest of Europe liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
51. Rest of Europe liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
52. AsiaPacific liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
53. AsiaPacific liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
54. AsiaPacific liquid biopsy market revenue, by application, 2016–2025 (USD Million)
55. AsiaPacific liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
56. Asia Pacific liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
57. Asia Pacific liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
58. China liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
59. China liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
60. China liquid biopsy market revenue, by application, 2016–2025 (USD Million)
61. China liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
62. China liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
63. China liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
64. Japan liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
65. Japan liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
66. Japan liquid biopsy market revenue, by application, 2016–2025 (USD Million)
67. Japan liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
68. Japan liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
69. Japan liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
70. India liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
71. India liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
72. India liquid biopsy market revenue, by application, 2016–2025 (USD Million)
73. India liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
74. India liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
75. India liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
76. Rest of Asia Pacific liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
77. Rest of Asia Pacific liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
78. Rest of Asia Pacific liquid biopsy market revenue, by application, 2016–2025 (USD Million)
79. Rest of Asia Pacific liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
80. Rest of Asia Pacific liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
81. Rest of Asia Pacific liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
82. Latin America liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
83. Latin America liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
84. Latin America liquid biopsy market revenue, by application, 2016–2025 (USD Million)
85. Latin America liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
86. Latin America liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
87. Latin America liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
88. Brazil liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
89. Brazil liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
90. Brazil liquid biopsy market revenue, by application, 2016–2025 (USD Million)
91. Brazil liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
92. Brazil liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
93. Brazil liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
94. Rest of Latin America liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
95. Rest of Latin America liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
96. Rest of Latin America liquid biopsy market revenue, by application, 2016–2025 (USD Million)
97. Rest of Latin America liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
98. Rest of Latin America liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
99. Rest of Latin America liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)
100. The Middle East and Africa liquid biopsy market revenue, by target analyte, 2016–2025 (USD Million)
101. The Middle East and Africa liquid biopsy market revenue, by analytical, 2016–2025 (USD Million)
102. The Middle East and Africa liquid biopsy market revenue, by application, 2016–2025 (USD Million)
103. The Middle East and Africa liquid biopsy market revenue, by sample, 2016–2025 (USD Million)
104. The Middle East and Africa liquid biopsy market revenue, by cancer type, 2016–2025 (USD Million)
105. The Middle East and Africa liquid biopsy market revenue, by end-use, 2016–2025 (USD Million)

Methodology

FrequentlyAsked Questions

The liquid biopsy is a non-invasive diagnostic test that analyses biological fluids, including blood, urine, and saliva, to detect and monitor diseases, particularly cancer. In contrast to conventional tissue biopsies, which necessitate surgical procedures to acquire a sample from the tumour, liquid biopsies identify biomarkers such as circulating tumour cells (CTCs), cell-free DNA (cfDNA), or exosomes that are liberated from tumours and released into the bloodstream or other bodily fluids.

The accuracy and efficacy of liquid biopsies have been improved by technological advancements in genomics, such as next-generation sequencing (NGS). The demand for liquid biopsies is also increased by the transition to precision medicine, which involves the customisation of treatments based on the genetic profiles of individual patients.

The global liquid biopsy market size was worth around USD 5.71 billion in 2023 and is predicted to grow to around USD 16.22 billion by 2032.

The global liquid biopsy market a compound annual growth rate (CAGR) of roughly 12.3% between 2024 and 2032.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players in the global liquid biopsy market include Biocept, Cynvenio, NeoGenomics Laboratories, Qiagen, Trovagene, RainDance Technologies, Guardant Health, Exosome Diagnostics, SAGA Diagnostics AB, Circulogene Theranostics, Inivata, Agena Bioscience, Admeria Health Personal Genome Diagnostics, and Adaptive Biotechnologies.

Choose License Type

  • zion payment modes

List of Contents

Industry Prospective:Growth DriversSegmentationReport ScopeRegional AnalysisCompetitive AnalysisThis report segments the global liquid biopsy market into:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed